摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-isopropenylpyrazole | 25834-28-0

中文名称
——
中文别名
——
英文名称
1-isopropenylpyrazole
英文别名
N-isopropenylpyrazole;1-isopropenyl-1H-pyrazole;1-prop-1-en-2-ylpyrazole
1-isopropenylpyrazole化学式
CAS
25834-28-0
化学式
C6H8N2
mdl
——
分子量
108.143
InChiKey
YDTGBSDMQIKOIT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    64 °C(Press: 30 Torr)
  • 密度:
    0.94±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    8
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    17.8
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    1-isopropenylpyrazole 、 zinc(II) chloride 以 乙醚 为溶剂, 以18%的产率得到2ZnCl2*3(1-isopropenylpyrazole)
    参考文献:
    名称:
    Complex Compounds Based on 1-Isopropenylimidazoles and -pyrazole
    摘要:
    关于 Co2+、Ni2+、Zn2+、Cd2+、Cu2+、Pd2+ 和 Sn4+ 盐,1-异丙烯基取代的咪唑、2-甲基咪唑和吡唑分别表现为 N1 原子和 N2 原子上只有一个配位中心的单配位配体;1-异丙烯基吡唑在络合物形成条件下脱烷形成吡唑络合物。与盐酸反应后,1-异丙烯基咪唑中的不饱和取代基保持不变,并通过杂环的 N3 原子生成相应的氢氯化物。碱性最低的 1-异丙烯基吡唑也会通过烯基的双键吸收 HCl。
    DOI:
    10.1007/s11176-005-0412-x
  • 作为产物:
    描述:
    吡唑丙二烯氢氧化钾 作用下, 以 二甲基亚砜 为溶剂, 反应 6.0h, 以46%的产率得到1-isopropenylpyrazole
    参考文献:
    名称:
    摘要:
    A number of previously unknown N-isopropenyl-substituted pyrroles, indoles, and di- and -triazoles were synthesized in 20-86% yield by reaction of the corresponding azole with an equilibrium mixture of propyne with allene or pure propyne and allene in the system KOH-DMSO (105-145degreesC, 5-15 h, atmospheric or elevated pressure). The reaction is regioselective. The electronic and steric structure and the degree of conjugation between the exocyclic double bond and the azole ring are discussed on the basis of the H-1 and C-13 NMR spectra. Almost complete absence of p-pi conjugation in alpha,alpha'-disubstitutecl N-isopropenylazoles have been found.
    DOI:
    10.1023/a:1025502016921
点击查看最新优质反应信息

文献信息

  • ACYLGUANIDINES FOR TREATING OSTEOARTHRITIS
    申请人:MERCK PATENT GMBH
    公开号:US20150361037A1
    公开(公告)日:2015-12-17
    The present invention relates to compounds of the formula (I) and in particular to medicaments comprising at least one compound of the formula I for use in the treatment and/or prophylaxis of physiological and/or pathophysiological conditions in the triggering of which cathepsin D is involved, in particular for use in the treatment and/or prophylaxis of osteoarthritis, traumatic cartilage injuries, arthritis, pain, allodynia or hyperalgesia.
    本发明涉及公式(I)的化合物,特别是涉及至少一种公式I化合物构成的药物,用于治疗和/或预防在其中天冬氨酸蛋白酶D参与的生理和/或病理生理状况,特别是用于治疗和/或预防骨关节炎、创伤性软骨损伤、关节炎、疼痛、触痛或过敏性疼痛。
  • C-PHENYL GLYCITOL COMPOUND
    申请人:Kakinuma Hiroyuki
    公开号:US20100022460A1
    公开(公告)日:2010-01-28
    Provided is a novel C-phenyl glycitol compound that may serve as a prophylactic or therapeutic agent for diabetes by inhibiting both SGLT1 activity and SGLT2 activity, thereby exhibiting a glucose absorption suppression action and a urine glucose excretion action. A C-phenyl glycitol compound represented by Formula (I) below or a pharmaceutically acceptable salt thereof or a hydrate thereof wherein R 1 and R 2 are the same or different and represent a hydrogen atom, a hydroxyl group, a C 1-6 alkyl group, a C 1-6 alkoxy group or a halogen atom, R 3 is a hydrogen atom, a C 1-6 alkyl group, a C 1-6 alkoxy group or a halogen atom, Y is a C 1-6 alkylene group, —O—(CH 2 )n— (n is an integer of 1 to 4) or a C 2-6 alkenylene group, provided that when Z is —NHC(═NH)NH 2 or —NHCON(R B )R C , n is not 1, Z is —CONHR A , —NHC(═NH)NH 2 or —NHCON(R B )R C ,
    提供的是一种新型C-苯基甘露醇化合物,可以作为预防或治疗糖尿病的药物,通过抑制SGLT1活性和SGLT2活性,从而表现出抑制葡萄糖吸收和尿液葡萄糖排泄的作用。该化合物表示为以下式子(I)的C-苯基甘露醇化合物,或其药学上可接受的盐或水合物,其中R1和R2相同或不同,表示氢原子、羟基、C1-6烷基、C1-6烷氧基或卤素原子,R3表示氢原子、C1-6烷基、C1-6烷氧基或卤素原子,Y表示C1-6烷基、-O-(CH2)n-(n为1至4的整数)或C2-6烯基烷基,但当Z为-NHC(=NH)NH2或-NHCON(RB)RC时,n不为1,Z为CONHRA,-NHC(=NH)NH2或-NHCON(RB)RC。
  • 1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS
    申请人:Cubist Pharmaceuticals, Inc.
    公开号:US20130296293A1
    公开(公告)日:2013-11-07
    β-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D β-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
    本发明揭示了β-内酰胺酶抑制剂化合物(BLIs),包括对A类、C类或D类β-内酰胺酶具有活性的化合物。还揭示了制造BLIs的方法,以及在制备药物组合物和抗菌应用中使用这些化合物的方法。
  • ISOXAZOLE BETA-LACTAMASE INHIBITORS
    申请人:Calixa Therapeutics, Inc.
    公开号:US20140323459A1
    公开(公告)日:2014-10-30
    β-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D β-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
    本发明公开了β-内酰胺酶抑制剂化合物(BLIs),包括对A类、C类或D类β-内酰胺酶具有活性的化合物。还公开了制造BLIs的方法,以及在制备药物组合物和抗菌应用中使用这些化合物的方法。
  • TREAD RUBBER COMPOSITION AND PNEUMATIC TIRE
    申请人:Sumitomo Rubber Industries, Ltd.
    公开号:EP2857446A1
    公开(公告)日:2015-04-08
    Provided are a tread rubber composition that can achieve a balanced improvement in fuel economy, wet-grip performance, and abrasion resistance, and a pneumatic tire including the composition. The tread rubber composition includes: a rubber component; silica; and a silane-coupling agent containing a mercapto group, the rubber component including per 100% by mass thereof 5% by mass or more of a conjugated diene polymer (A), the polymer (A) including a monomer unit derived from a conjugated diene, a monomer unit derived from a compound of formula (1), and a monomer unit derived from a compound of formula (2), at least one end of the copolymer (A) being modified by the following compound (G) or an alkoxysilane compound, the composition including 5-150 parts by mass of the silica per 100 parts by mass of the rubber component, Compound (G): at least one compound selected from the group consisting of compounds containing an optionally-substituted amino group and a carbonyl group and compounds containing an optionally-substituted amino group and a thiocarbonyl group,         V1-S1     (1)         V2-A2     (2) wherein V1 and V2 each represent a hydrocarbyl group containing a polymerizable carbon-carbon double bond; S1 represents a substituted silyl group, and A2 represents a substituted amino group or a nitrogen-containing heterocyclic group.
    本文提供了一种可均衡改善燃油经济性、湿抓地性能和耐磨性的胎面橡胶组合物,以及一种包含该组合物的充气轮胎。胎面橡胶组合物包括橡胶成分;白炭黑和含有巯基的硅烷偶联剂,橡胶成分包括每 100% 质量中 5%(质量)或更多的共轭二烯聚合物 (A),聚合物 (A) 包括衍生自共轭二烯的单体单元、衍生自式 (1) 化合物的单体单元和源自式(2)化合物的单体单元,共聚物(A)的至少一端由下列化合物(G)或烷氧基硅烷化合物改性,该组合物包括每 100 份(质量)橡胶成分中含 5-150 份(质量)二氧化硅的化合物(G):至少一种选自以下组别的化合物:含有任选取代的氨基和羰基的化合物,以及含有任选取代的氨基和硫代羰基的化合物、 V1-S1 (1) V2-A2 (2) 其中 V1 和 V2 分别代表含有可聚合碳碳双键的烃基,S1 代表取代的硅烷基,A2 代表取代的氨基或含氮杂环基。
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺